Pigs aerogenously immunized with genetically inactivated (ghosts) or irradiated Actinobacillus pleuropneumoniae are protected against a homologous aerosol challenge despite differing in pulmonary cellular and antibody responses
A. Katinger et al., Pigs aerogenously immunized with genetically inactivated (ghosts) or irradiated Actinobacillus pleuropneumoniae are protected against a homologous aerosol challenge despite differing in pulmonary cellular and antibody responses, J BIOTECH, 73(2-3), 1999, pp. 251-260
Aerosol immunization is a safe way to induce complete protection against pl
europneumonia in pigs caused by the lung pathogenic bacterium Actinobacillu
s pleuropneumoniae. In order to determine the local immune responses of vac
ciness in concomitant with protection, lung lining fluid before and 3 weeks
after immunization from pigs immunized three times with aerosols of either
genetically inactivated ghosts which represent whole cell envelope prepara
tions, or irradiated bacteria were examined following an homologous aerosol
challenge. Specific antibody isotypes in the bronchoalveolar lavage were a
ssayed by whole cell ELISAs. Total and relative numbers of cells including
lymphocyte subsets were determined. In both vaccinated groups a net influx
of plasma cells and lymphocytes, as well as a significant increase of speci
fic IgG occurred. Concurrently, the CD4(+)/CD8(+) ratio was found to increa
se after aerosol immunization. The lymphocyte subsets of IgG(+) and IgA(+)
cells were found significantly higher in the group immunized with irradiate
d bacteria when compared to pigs immunized with bacterial ghosts. The latte
r group showed a significant increase of IgA, IgM, and a net influx of lymp
hoid blasts and granulocytes in the bronchoalveolar lining fluid. Although
differences between the local immune responses of both immunized groups occ
urred, a significant increase of specific IgG and a net influx of plasma ce
lls and lymphocytes were found to be associated with complete protection ag
ainst a homologous aerosol challenge infection. (C) 1999 Elsevier Science B
.V. All rights reserved.